Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
CAMA-1
HR+
Luminal
FTase Inhibitor I
Ftase
MAPK
10473.142
uM
inf
inf
0.9428 0.9428 0.0000 0.0415
-0.0641
1.0815
CAMA-1
HR+
Luminal
Lestaurtinib
FLT3/JAK2/TrkA
RTK
10473.142
uM
5.70560
9.9930
-0.9793 -0.9990 1.9591 0.3434
0.9972
1.0815
HCC1187
TNBC
Basal A
Baicalein
Lipoxygenase
Metabolism
10518.072
uM
8.05840
44.66590
-0.4627 -1.0000 0.6415 0.3266
0.9675
1.2152
HCC1187
TNBC
Basal A
Omipalisib
PI3K
PI3K
10518.087
uM
0.00488
0.02658
-0.7747 -0.7029 0.5176 0.9208
0.9758
1.1688
HCC1187
TNBC
Basal A
IKK16
IKK
NFKB
10518.1
uM
3.67090
4.54520
-0.9524 -0.9540 4.9962 0.4542
0.9876
1.4056
HCC1187
TNBC
Basal A
TPCA-1
IKK
NFKB
10518.1
uM
1.72660
4.80140
-0.1947 -0.4091 0.5845 0.4171
0.980
1.4056
HCC1187
TNBC
Basal A
PD173074
FGFR1/3
RTK
10518.1
uM
11.85830
18.21780
-0.9484 -1.0000 2.5586 0.2835
0.9690
1.4056
HCC1187
TNBC
Basal A
Pevonedistat
NAE1
NAE1
10518.135
uM
1.13960
1.24570
-0.1218 -0.0812 1.6904 0.3563
0.9831
1.1446
HCC1187
TNBC
Basal A
TCS PIM-1 1
Pim kinase
PIM
10518.135
uM
inf
inf
0.4907 0.4907 0.0000 0.1417
0.0602
1.1446
HCC1187
TNBC
Basal A
PD 98059
MEK
MAPK
10518.136
uM
5.70580
6.65780
-0.0226 -0.0746 0.9009 0.2276
0.9698
1.2490
HCC1187
TNBC
Basal A
Sulindac sulfide
COX1/2
COX
10518.136
uM
927.95440
1000.00000
0.7851 -0.0259 0.6766 0.0394
0.6183
1.2490
HCC1187
TNBC
Basal A
Celecoxib
COX2
COX
10518.136
uM
inf
inf
0.9091 0.9091 0.0000 0.0220
0.1805
1.2490
HCC1187
TNBC
Basal A
FR180204
ERK1/2
MAPK
10518.137
uM
25.61280
147.06970
0.4349 -1.0000 0.6286 0.1216
0.7415
1.2405
HCC1187
TNBC
Basal A
L-779450
BRAF
MAPK
10518.137
uM
10.91310
8.45570
0.3599 0.3592 4.9678 0.0766
0.9090
1.2405
HCC1187
TNBC
Basal A
Glycyl-H-1152
ROCK2
10518.138
uM
0.43471
0.58591
-0.2990 -0.2511 1.3632 0.3973
0.9939
1.3413
HCC1187
TNBC
Basal A
ZM-447439
AURK
AURK
10518.138
uM
0.23611
0.23002
0.0120 0.0612 5.0000 0.4780
0.9213
1.3413
HCC1187
TNBC
Basal A
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
10518.138
uM
0.09728
0.11455
-0.5380 -0.2289 2.3063 0.6356
0.9308
1.3413
HCC1187
TNBC
Basal A
XRP44X
ELK3
MAPK
10518.139
uM
1.20340
1.41520
-0.7378 -0.6246 5.0000 0.5809
0.9830
1.2366
HCC1187
TNBC
Basal A
ICRF-193
TOP2
TOP
10518.139
uM
0.69804
0.96064
-0.1654 -0.1996 1.0518 0.3517
0.9913
1.2366
HCC1187
TNBC
Basal A
GW843682X
PLK
PLK
10518.139
uM
9.37850
81.90440
0.2153 -1.0000 0.5069 0.1636
0.9748
1.2366
HCC1187
TNBC
Basal A
Chk2 inhibitor II
CHK2
CHK
10518.14
uM
inf
9.15840
0.6700 0.6648 2.0740 0.0394
0.9522
1.2052
HCC1187
TNBC
Basal A
NSC 663284
CDC25
CDC
10518.14
uM
1.98340
2.49030
-0.9784 -0.9747 4.7532 0.6282
0.9973
1.2052
HCC1187
TNBC
Basal A
TCS 2312
CHK1
CHK
10518.14
uM
1.0160
1.24260
-0.8690 -0.8683 5.0000 0.4833
0.9979
1.2052
HCC1187
TNBC
Basal A
AS-252424
PI3K
PI3K
10518.141
uM
1.80660
1.25980
0.1622 0.1140 0.7180 0.2657
0.9263
1.3122
HCC1187
TNBC
Basal A
Sigma A6730
AKT
AKT
10518.141
uM
4.60660
11.04240
-0.9668 -1.0000 1.2566 0.3372
0.9742
1.3122